Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 556
Year : 2014  |  Volume : 6  |  Issue : 2  |  Page : 71-76

Glycemic management after antenatal corticosteroid therapy

1 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
2 Department of Obstetrics and Gynecology, Bharti Hospital, Karnal, Haryana, India
3 Department of Medicine, Government Medical College and Hospital, Chandigarh, India

Correspondence Address:
Sanjay Kalra
Department of Endocrinology, Bharti Hospital, Kunjpura Road, Karnal, Haryana -132 001
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1947-2714.127744

Rights and Permissions

Antenatal corticosteroids (ACS) are recommended for use in antenatal mothers at risk of preterm delivery before 34 weeks. One common side-effect of these drugs is their propensity to cause hyperglycemia. A PubMed search was made using terms 'steroid,' 'dexamethasone,' 'betamethasone' with diabetes/glucose. Relevant articles were extracted. In addition, important cross-reference articles were reviewed. This review, based upon this literature search, discusses the available evidence on effects on glycemic status as well as management strategies in women with pre-existing diabetes, gestational diabetes mellitus, as well as normoglycemic women after ACS use in pregnancy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1030    
    Comments [Add]    
    Cited by others 17    

Recommend this journal